FDA draft guidance for modernizing the approach to clinical trial design for oncology drugs and biologics look to make clinical trials more efficient while maintaining patient safety.
Jeffrey Hodge
Advertisement
Articles by Jeffrey Hodge
Advertisement
Latest Updated Articles
Master Protocol Guidance in Cancer R&D: Impact on IndustryPublished: June 14th 2019 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor
2
Future-Proofing Clinical Trial Supply Chains Against Tariff Risks
3
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
4
After the Trial is too Late: The Case for More Active Use of Patient-Reported Outcomes in Oncology Studies
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
